• Citing Article List

    The journal uses Crossref Cited-by service counts times cited of published articles. Cited-by allows Crossref members to find out who is citing their content. This is the Citing Article List of “Integration of PARP-inhibitors in ovarian cancer therapy”.
    No. Publication Date Citing Article
    1 2021 D. Lorusso, G. Daniele. First line ovarian cancer treatment: Scanning the horizon, Critical Reviews in Oncology/Hematology. 2021; 160: 103297103297.  https://doi.org/10.1016/j.critrevonc.2021.103297
    2 2020 Domenica Lorusso, Valentina Ceni, Margherita Muratore, Vanda Salutari, Camilla Nero, Antonella Pietragalla, Francesca Ciccarone, Vittoria Carbone, Gennaro Daniele, Giovanni Scambia. Emerging role of immune checkpoint inhibitors in the treatment of ovarian cancer, Expert Opinion on Emerging Drugs. 2020; 25: 445.  https://doi.org/10.1080/14728214.2020.1836155
    3 2024 Ricardo G. Teixeira, Alessia Stefanelli, Adhan Pilon, Rebecca Warmers, Xavier Fontrodona, Isabel Romero, Paulo J. Costa, Maria J. Villa de Brito, Xenia Hudec, Christine Pirker, Sebastian Türck, Alexandra M. M. Antunes, Christian R. Kowol, Ingo Ott, Anamaria Brozovic, Andy Sombke, Margret Eckhard, Ana Isabel Tomaz, Petra Heffeter, Andreia Valente. Paraptotic Cell Death as an Unprecedented Mode of Action Observed for New Bipyridine-Silver(I) Compounds Bearing Phosphane Coligands, Journal of Medicinal Chemistry. 2024; 67: 6081.  https://doi.org/10.1021/acs.jmedchem.3c01036